- All sections
- C - Chemistry; metallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 233/00 - Carboxylic acid amides
Patent holdings for IPC class C07C 233/00
Total number of patents in this class: 320
10-year publication summary
12
|
10
|
4
|
10
|
18
|
12
|
11
|
9
|
8
|
3
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2961 |
9 |
Bristol-myers Squibb Company | 5080 |
6 |
Takeda Pharmaceuticals U.S.A., Inc. | 139 |
6 |
Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences | 112 |
6 |
Massachusetts Institute of Technology | 9795 |
4 |
Ramot at Tel-Aviv University Ltd. | 1370 |
4 |
Merck & Co., Inc. | 607 |
3 |
Allergan, Inc. | 2600 |
3 |
Bayer AG | 3045 |
3 |
Abbvie Inc. | 1808 |
3 |
Council of Scientific & Industrial Research | 1397 |
3 |
Givaudan SA | 1760 |
3 |
Kinex Pharmaceuticals, LLC | 12 |
3 |
Les Laboratoires Servier | 599 |
3 |
Milliken & Company | 1253 |
3 |
MPC Merger Sub, Inc. | 12 |
3 |
MPC Oldco, Inc. | 11 |
3 |
Reata Pharmaceuticals, Inc. | 127 |
3 |
Tempero Pharmaceuticals, Inc. | 23 |
3 |
Calico Life Sciences LLC | 71 |
3 |
Other owners | 243 |